Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

494
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
494
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.1K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

The Lancet. Oncology·2026
Same author

Thirty-Five years of globalizing surgical oncology knowledge: A look into the future - IASGO Cairo 2024.

Surgical oncology·2025
Same author

Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.

Annals of surgery·2025
Same author

Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review.

Medicina (Kaunas, Lithuania)·2025
Same author

Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition.

Journal of hepato-biliary-pancreatic sciences·2024
Same author

Corrigendum to "The 2016 update of the International Study Group (ISGPF) definition and grading of postoperative pancreatic fistula: eleven years after." Surgery 2017. Mar; 161 (3):584-591. Epub Dec 28, 2016.

Surgery·2024

Related Experiment Video

Updated: Apr 4, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

5.3K

Screening for Pancreatic Cancer.

Keita Wada1, Kyoichi Takaori2, L William Traverso3

  • 1Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

The Surgical Clinics of North America
|August 29, 2015
PubMed
Summary

Pancreatic cancer survival has not improved with surgery alone. Early detection and screening are crucial for identifying operable tumors, offering the only chance for a cure through surgical resection.

Keywords:
Familial pancreatic cancerIntraductal papillary mucinous neoplasmPancreatic cancerPancreatic intraepithelial neoplasiaScreening

More Related Videos

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.9K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

843

Related Experiment Videos

Last Updated: Apr 4, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

5.3K
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.9K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

843

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer has a poor prognosis, with most cases diagnosed at advanced, metastatic stages.
  • Current surgical approaches and expanded indications have not improved patient survival rates.
  • Complete tumor removal in the early stages is the only known curative treatment for pancreatic cancer.

Purpose of the Study:

  • To review the evidence and methods for screening individuals at risk for pancreatic cancer.
  • To discuss indications for early-stage surgical resection and identify precursor lesions.
  • To emphasize the importance of surgeon awareness regarding screening protocols.

Main Methods:

  • Review of existing literature on pancreatic cancer screening.
  • Analysis of autopsy data to determine metastatic rates.
  • Discussion of familial and sporadic screening strategies.
  • Examination of early-stage surgical criteria and precursor identification.

Main Results:

  • A significant majority of pancreatic cancer cases (approximately 90%) are metastatic at autopsy.
  • Early-stage detection and complete surgical resection offer the only potential for cure.
  • Screening methods for familial and sporadic risk groups are under investigation.

Conclusions:

  • Early detection and screening are paramount for improving pancreatic cancer outcomes.
  • Surgical resection in the early, non-metastatic stage provides the only chance for cure.
  • Surgeons must be knowledgeable about screening to identify eligible patients for curative surgery.